Progenics Pharmaceuticals Inc — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e69d99da-0c8b-4f01-828d-3ff8511f14ce/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2019 | $35.0M | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-005145 |
| FY 2018 | $15.6M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-004951 |
| FY 2017 | $11.7M | 2017-01-01 – 2017-12-31 | evidence 0001437749-19-004951 |
| FY 2016 | $69.4M | 2016-01-01 – 2016-12-31 | evidence 0001437749-19-004951 |
| FY 2015 | $8.7M | 2015-01-01 – 2015-12-31 | evidence 0000835887-16-000131 |
| FY 2014 | $44.4M | 2014-01-01 – 2014-12-31 | evidence 0000835887-15-000020 |
| FY 2013 | $7.9M | 2013-01-01 – 2013-12-31 | evidence 0000835887-14-000027 |
| FY 2012 | $14.0M | 2012-01-01 – 2012-12-31 | evidence 0000835887-13-000017 |
| FY 2011 | $84.8M | 2011-01-01 – 2011-12-31 | evidence 0000835887-13-000017 |
| FY 2010 | $8.0M | 2010-01-01 – 2010-12-31 | evidence 0000835887-13-000017 |
| FY 2009 | $48.9M | 2009-01-01 – 2009-12-31 | evidence 0000835887-12-000012 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Progenics Pharmaceuticals Inc — all facts · Net Income · Operating Income